What is the recommended treatment for a great toe infection, specifically using Keflex (cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) for Great Toe Infection

For mild great toe infections, cephalexin (Keflex) 500 mg orally twice daily for 1-2 weeks is the recommended first-line treatment, as it effectively targets the gram-positive cocci that commonly cause these infections. 1, 2

Infection Assessment and Classification

  • Great toe infections should be classified based on severity to guide appropriate treatment 1:

    • Mild: Presence of ≥2 manifestations of inflammation (erythema, warmth, tenderness, pain, induration) limited to the skin and superficial subcutaneous tissues
    • Moderate: Infection extending deeper than skin/subcutaneous tissues or involving deeper structures
    • Severe: Accompanied by systemic inflammatory response signs
  • Obtain appropriate wound cultures before starting antibiotics to guide definitive therapy, especially if there are risk factors for resistant organisms 3

Antibiotic Selection

  • For mild great toe infections without complicating factors, cephalexin is an appropriate first-line choice as it targets gram-positive cocci (Staphylococcus aureus and Streptococcus species) 1, 2

  • Dosing recommendations:

    • Standard adult dose: 500 mg orally twice daily 2
    • Adjust dosing in patients with renal impairment (creatinine clearance <30 ml/min) 4
  • Alternative options if patient has β-lactam allergy or intolerance 1:

    • Clindamycin
    • Trimethoprim-sulfamethoxazole
    • Doxycycline
    • Fluoroquinolones (levofloxacin, moxifloxacin)

Special Considerations

  • Consider broader coverage if the patient has 1, 3:

    • Recent antibiotic exposure
    • History of MRSA colonization or infection
    • Diabetes
    • Immunocompromised status
  • For diabetic patients with great toe infections, cephalexin is still appropriate for mild infections, but consider broader coverage for moderate-to-severe infections 1

  • If MRSA is suspected, alternative agents should be considered such as trimethoprim-sulfamethoxazole, clindamycin, or linezolid 1

Duration of Therapy

  • For mild great toe infections: 1-2 weeks of antibiotic therapy is usually sufficient 3
  • For moderate infections: 1-3 weeks may be required 1
  • For infections involving bone (osteomyelitis): longer therapy (often 4-6 weeks) is typically needed 1

Comprehensive Management

  • Antibiotic therapy alone is insufficient; appropriate wound care is crucial 3:
    • Proper wound cleansing
    • Debridement of callus and necrotic tissue if present
    • Off-loading of pressure on the affected area
    • Regular wound assessment and follow-up

Monitoring and Follow-up

  • Monitor for clinical improvement within 48-72 hours 3
  • If no improvement is seen, consider:
    • Broadening antibiotic coverage
    • Obtaining cultures if not done initially
    • Reassessing for deeper infection or osteomyelitis
    • Surgical consultation if indicated 1

Common Pitfalls to Avoid

  • Treating clinically uninfected wounds with antibiotics is not recommended, even in diabetic patients 5
  • Continuing antibiotics beyond resolution of infection signs is unnecessary and may contribute to antibiotic resistance 5
  • Failing to adjust dosing in patients with renal impairment 4
  • Overlooking the possibility of osteomyelitis in persistent infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Mild Diabetic Foot Infection in Kidney Transplant Recipients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Antibiotic Management for Diabetic Wound with Granulation Tissue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.